Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$940M |
| 2 |
SPDR Gold Trust
GLD
|
+$375M |
| 3 |
Citigroup
C
|
+$202M |
| 4 |
Gilead Sciences
GILD
|
+$150M |
| 5 |
Macy's
M
|
+$81.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.28B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$700M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$500M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$396M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.93% |
| 2 | Technology | 1.75% |
| 3 | Financials | 1.43% |
| 4 | Consumer Discretionary | 0.87% |
| 5 | Healthcare | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4926
ProShares VIX Mid-Term Futures ETF
VIXM
$154M
| $971K | ﹤0.01% |
18,480
+4,379
| +31% | +$234K |
|
|
FOLD
4927
PUT
DELISTED
Amicus Therapeutics
FOLD
| $970K | ﹤0.01% |
177,700
+64,600
| +57% | +$452K |
|
4928
CALL
Genpact
G
$6.39B
| $969K | ﹤0.01% |
36,100
+26,400
| +272% | +$726K |
|
4929
State Street SPDR S&P Transportation ETF
XTN
$369M
| $969K | ﹤0.01% |
+22,238
| New | +$994K |
|
|
BLOX
4930
DELISTED
Infoblox Inc
BLOX
| $969K | ﹤0.01% |
+51,648
| New | +$895K |
|
4931
PUT
ING
ING
$101B
| $968K | ﹤0.01% |
93,700
-71,600
| -43% | -$849K |
|
|
PDCE
4932
DELISTED
PDC Energy, Inc.
PDCE
| $968K | ﹤0.01% |
16,809
+4,518
| +37% | +$268K |
|
|
GXP
4933
PUT
DELISTED
Great Plains Energy Incorporated
GXP
| $967K | ﹤0.01% |
+31,800
| New | +$976K |
|
4934
CALL
Madison Square Garden
MSGS
$9.38B
| $966K | ﹤0.01% |
7,851
-16,404
| -68% | -$1.93M |
|
|
ASNA
4935
PUT
DELISTED
Ascena Retail Group, Inc.
ASNA
| $966K | ﹤0.01% |
6,910
-4,615
| -40% | -$748K |
|
4936
CALL
Black Hills Corp
BKH
$5.55B
| $965K | ﹤0.01% |
15,300
+1,000
| +7% | +$60.3K |
|
4937
PUT
Carlyle Group
CG
$17.5B
| $964K | ﹤0.01% |
59,400
+32,900
| +124% | +$539K |
|
4938
PUT
Gartner
IT
$12.5B
| $964K | ﹤0.01% |
9,900
+200
| +2% | +$19K |
|
|
EPIQ
4939
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $964K | ﹤0.01% |
66,046
+50,786
| +333% | +$744K |
|
4940
CBIZ
CBZ
$2.96B
| $963K | ﹤0.01% |
92,513
-14,218
| -13% | -$146K |
|
4941
PUT
HDFC Bank
HDB
$119B
| $962K | ﹤0.01% |
58,000
-130,000
| -69% | -$2.07M |
|
|
IPXL
4942
DELISTED
Impax Laboratories, Inc.
IPXL
| $962K | ﹤0.01% |
33,367
-40,763
| -55% | -$1.33M |
|
4943
PUT
Celldex Therapeutics
CLDX
$3.07B
| $961K | ﹤0.01% |
14,593
-254
| -2% | -$16.1K |
|
4944
Direxion Daily MSCI India Bull 2X ETF
INDL
$56.2M
| $960K | ﹤0.01% |
+19,049
| New | +$906K |
|
4945
State Street SPDR S&P Insurance ETF
KIE
$709M
| $960K | ﹤0.01% |
40,518
-30,489
| -43% | -$716K |
|
4946
J.M. Smucker
SJM
$14.1B
| $960K | ﹤0.01% |
6,300
-2,048
| -25% | -$272K |
|
|
SYNH
4947
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $959K | ﹤0.01% |
25,156
-19,810
| -44% | -$870K |
|
|
ARR
4948
PUT
Armour Residential REIT
ARR
$2.31B
| $958K | ﹤0.01% |
9,580
+900
| +10% | +$91.2K |
|
4949
RLJ Lodging Trust
RLJ
$1.75B
| $958K | ﹤0.01% |
44,637
-104,426
| -70% | -$2.22M |
|
4950
Wintrust Financial
WTFC
$10.3B
| $958K | ﹤0.01% |
18,791
+14,172
| +307% | +$709K |
|
Similar funds
Jeff Yass's Q2 2016 Portfolio in Review
As of Q2 2016, Jeff Yass held 10,185 positions worth $187B, down 0.75% from $188B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass withdrew a net $15.2B in Q2 2016, closing 1,718 positions and reducing 3,507 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $700M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 90% a quarter earlier, followed by Technology and Financials.
Against the trend, Jeff Yass opened a new position in Vanguard Long-Term Bond ETF worth $47.5M.
- Jeff Yass's largest Q2 2016 buy was Vanguard Long-Term Bond ETF: 484,542 shares worth $47.5M.
- Jeff Yass added most to Apple in Q2 2016, an estimated $940M increase.
- Jeff Yass's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.28B.
- Jeff Yass fully exited iShares MSCI Emerging Markets ETF in Q2 2016, selling an estimated $700M.
- Jeff Yass's ten largest holdings make up 24% of its $187B portfolio in Q2 2016.
- Jeff Yass opened 1,269 new positions and closed 1,718 in Q2 2016.
- Jeff Yass's portfolio value fell 0.75% quarter-over-quarter to $187B.
Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.